[Clinical use of podophyllin derivatives SP-I and SP-G in the treatment of cancer].
D000328:Adult; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*; D010946:Plants, Medicinal; D010947:Plants, Toxic; D011033:Podophyllin / Q000009:adverse effects / Q000627:therapeutic use; D011035:Podophyllum
D011033:Podophyllin